NMI 8000Alternative Names: Mullerian inhibitory substance - Nemucore; NMI-8000; rhMIS - Nemucore
Latest Information Update: 17 Dec 2015
At a glance
- Originator Massachusetts General Hospital; Nemucore Medical Innovations
- Developer Massachusetts General Hospital; Nemucore Medical Innovations; Pfenex
- Class Proteins; Transforming growth factors
- Mechanism of Action Anti-Mullerian hormone receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Gynaecological cancer; Ovarian cancer